Alistair Henry

I am passionate about transforming the future of healthcare through innovation, collaboration, and an unwavering focus on the patient - every decision, every innovation, and every step forward is guided by the desire to elevate their lives through our medicines. At UCB, our research efforts begin by focusing on uncovering the molecular and biological complexities of diseases. By gaining a clearer insight into disease characterization and pathobiology, using insights provided by genomics and proteomics, we can uncover how diseases develop, progress, and impact the human body. A deeper knowledge of how molecular disease pathways (the intricate biological mechanisms that drive illness), operate is essential as it enables the discovery of novel interventions to target the root causes of disease and ultimately allow us to take meaningful strides toward transforming healthcare. My role as Chief Scientific Officer allows me to oversee teams that are compassionate, curious, and with a shared purpose – break new ground to deliver highly differentiated medicines, medicines that have the potential to not only transform lives but, ultimately, cure diseases. Being part of this fuels me every day.